Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
01-Aug-25 | Buy | Martin Diggle | 10.00p | 4,400,000 | £440,000.01 |
30-Jul-25 | Buy | Martin Diggle | 10.00p | 5,000,000 | £500,000.01 |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
30-Jul-25 | Buy | Martin Diggle | 10.00p | 5,000,000 | £500,000.01 |
01-Aug-25 | Buy | Martin Diggle | 10.00p | 4,400,000 | £440,000.01 |
Notifier | Holding | Value* |
---|---|---|
Martin Diggle | 140,284,801 | £14,589,619 |
Jean-Michel Cosséry | 454,545 | £47,273 |
Lindy Durrant | 272,727 | £28,364 |
Notifier** | Holding | Value* |
---|---|---|
Redmile Group, LLC | 268,616,936 | £27,936,161 |
VULPES LIFE SCIENCES FUND | 117,729,029 | £12,243,819 |
VULPES LIFE SCIENCES FUND | 117,479,029 | £12,217,819 |
Ferlim Nominees Limited | 50,632,079 | £5,265,736 |
Reyker Nominees Ltd | 48,464,691 | £5,040,328 |
Hargreaves Lansdown | 33,619,839 | £3,496,463 |
Share Nominees Ltd. | 29,887,768 | £3,108,328 |
The Bank of New York Nominees Limited | 21,287,775 | £2,213,929 |
Legal & General Group Plc | 18,167,000 | £1,889,368 |
Nortrust Nominees Limited | 18,167,000 | £1,889,368 |
City Financial Investment Company Limited | 16,287,775 | £1,693,929 |
Barclayshare Nominees Ltd | 15,650,629 | £1,627,665 |
Lynchwood Nominees Ltd. | 15,085,721 | £1,568,915 |
Rock Nominees Limited | 13,445,702 | £1,398,353 |
Hygea VCT | 13,149,730 | £1,367,572 |
Huntress Nominees (CI) Limited | 11,309,220 | £1,176,159 |
Layton Trustees & L.G. Durrant | 8,773,960 | £912,492 |
JG Helfenstein | 7,000,000 | £728,000 |
Currency | UK Pounds |
Share Price | 10.40p |
Change Today | 0.15p |
% Change | 1.46 % |
52 Week High | 19.50 |
52 Week Low | 7.50 |
Volume | 159,243 |
Shares Issued | 1,037.78m |
Market Cap | £107.93m |
Value | ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
Strong Buy | 1 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 3 |
No dividends found |
CFO | Sath Nirmalananthan |
CEO | Phil L'Huillier |
You are here: research